Literature DB >> 25879536

HIV Tat protein: Is Tat-C much trickier than Tat-B?

Manish Kumar Johri1, Nikhil Sharma1, Sunit K Singh1.   

Abstract

Out of various subtypes of human immunodeficiency virus type 1 (HIV-1), subtype B and C cause most of the infections worldwide. Clade specific differences have been reported in differences in clinical picture of HIV pathogenesis. Transcription of the HIV-1 genome is regulated by the interaction of HIV Tat protein to the trans-activation response (TAR) element. The differential binding of clade B and C Tat proteins to TAR and differences in activation of NF-κB cascade leading to differential transactivation capacity and cytokine expression has been examined in this study. More stable Tat-TAR complex formation by Tat-C revealed by EMSA and higher TNF-α expression shown by Tat-C compared to Tat-B leads to higher NF-κB activation, which may be plausible cause for higher transactivation by Tat-C as obtained by FACS analysis. This comparative study would be helpful in understanding the basic mechanism of clade specific Tat protein differences and their functional relationships.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  HIV; HIV Tat protein; HIV pathogenesis; NF-κB activation; cytokines; neuropathogenesis

Mesh:

Substances:

Year:  2015        PMID: 25879536     DOI: 10.1002/jmv.24182

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

Review 1.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

2.  Molecular Modeling of Subtype-Specific Tat Protein Signatures to Predict Tat-TAR Interactions That May Be Involved in HIV-Associated Neurocognitive Disorders.

Authors:  Monray E Williams; Ruben Cloete
Journal:  Front Microbiol       Date:  2022-04-07       Impact factor: 5.640

3.  Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.

Authors:  Francesco Nicoli; Mkunde Chachage; Petra Clowes; Asli Bauer; Dickens Kowour; Barbara Ensoli; Aurelio Cafaro; Leonard Maboko; Michael Hoelscher; Riccardo Gavioli; Elmar Saathoff; Christof Geldmacher
Journal:  BMC Infect Dis       Date:  2016-07-22       Impact factor: 3.090

Review 4.  HIV-1 Tat: Role in Bystander Toxicity.

Authors:  David Ajasin; Eliseo A Eugenin
Journal:  Front Cell Infect Microbiol       Date:  2020-02-25       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.